SANDOZ Australia, in consultation with the Therapeutic Goods Administration (TGA), has announced a recall of two batches of Curam Duo 400/57 medication.
The TGA said an anomaly during the manufacture of the affected batches could result in a failure of the air-tight sealing system, allowing the entry of moisture, potentially degrading the product.
Curam Duo is a powder for oral suspension (60ml liquid when mixed) containing amoxicillin and potassium clavulanate.
It's used to treat a wide range of bacterial infections in adults and children, with the affected items being from batch numbers JC5418 and JC5419, expiring Jul 2021.
Consumers are being advised to return the items to their local pharmacy for a refund.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 May 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 May 19
